Single-Cell Analysis Transcriptomics Market Growth In 2026: Market Size, Key Drivers And Future Outlook
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Single-Cell Analysis Transcriptomics Market Forecast: Value Set To Climb From $1.22 Billion To $1.92 Billion
The single-cell analysis transcriptomics market has experienced significant growth in recent years, with its size projected to increase from $1.08 billion in 2025 to $1.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.3%. The market’s historical growth can be attributed to factors such as the high cost of early sequencing equipment, limited accessibility of microfluidics technologies, a reliance on conventional bulk tissue analysis, growing academic research funding, and an emerging awareness of cellular heterogeneity.
The single-cell analysis transcriptomics market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $1.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This anticipated growth during the forecast period is attributable to several factors, including advancements in single-cell sequencing platform technology, the incorporation of cloud-based bioinformatics solutions, increased capital allocation from pharmaceutical and biotechnology firms, broader implementation in personalized medicine, and the broadening scope of applications within hospitals and diagnostic centers. Key trends shaping the forecast period encompass a growing uptake of single-cell RNA sequencing methodologies, an increase in the deployment of microfluidics-based platforms, the widening application range in clinical diagnostics, an expansion of research efforts in drug discovery and development, and improvements in data analysis and bioinformatics functionalities.
Get A Free Sample Report With In-Depth Market Insights:
Single-Cell Analysis Transcriptomics Market Growth Drivers: What’s Behind The Acceleration?
The rising acceptance of personalized medicine is projected to fuel the expansion of the single-cell analysis transcriptomics market in the future. Personalized medicine represents a healthcare strategy that tailors therapies according to a patient’s unique genetic makeup, way of life, and surroundings. This growing uptake of personalized medicine stems from breakthroughs in genetic sequencing, which allow for treatments specifically designed for individual genetic profiles, enhancing their efficacy. Single-cell analysis transcriptomics reveals distinct gene expression profiles, thereby informing personalized treatment strategies that account for a patient’s specific biological characteristics. This technology improves the efficacy of therapies, reduces adverse reactions, and facilitates the early detection of diseases. For example, data from February 2024, provided by the Personalized Medicine Coalition, a US-based hospital and healthcare organization, indicates that the U.S. Food and Drug Administration sanctioned 16 novel personalized therapies for patients with rare diseases in 2023, a rise from 6 approvals in 2022. Consequently, the growing integration of personalized medicine acts as a primary catalyst for the expansion of the single-cell analysis transcriptomics market.
Single-Cell Analysis Transcriptomics Market Segment Breakdown: Which Categories Lead On Revenue?
The single-cell analysis transcriptomics market covered in this report is segmented –
1) By Component: Equipment, Consumables, Software And Services
2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies
3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training
Single-Cell Analysis Transcriptomics Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies active in the single cell analysis transcriptomics market are prioritizing the development of innovative offerings, such as single cell RNA sequencing kits, to streamline processes and enable deeper comprehension of cellular variability. A single cell RNA sequencing kit represents a specialized tool for isolating and analyzing gene expression at the level of individual cells. It allows researchers to reveal cellular diversity and gain insights into complex biological processes. For instance, in January 2024, Scale Biosciences, a US based biotechnology company specializing in single cell solutions, launched the Single Cell RNA Kit v1.1-Extended Throughput, enabling processing of up to 500,000 cells per run under an instrument free workflow. This release significantly enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.
Single-Cell Analysis Transcriptomics Market Leading Players And Competitive Positioning
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences
View The Full Single-Cell Analysis Transcriptomics Market Report:
Single-Cell Analysis Transcriptomics Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
